Myriad Genetics (MYGN) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Teknova (TKNO) has outperformed Myriad Genetics (MYGN) over the past year, gaining 66.2% versus a loss of 43.2%. Over five years, TKNO leads with a -62.3% price change compared with -86.5% for MYGN. Alpha Teknova is the larger company by market cap ($467.6 million vs $409.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MYGN | TKNO |
|---|---|---|
| Share price | $4.28 | $8.71 |
| Market cap | $409.38M | $467.62M |
| 1-day change | 0.00% | -0.46% |
| YTD return | -30.41% | +129.21% |
| 1-year return | -43.16% | +66.22% |
| 5-year return | -86.52% | -62.29% |
| EPS (TTM) | $-1.18 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.59 | $9.48 |
| 52-week low | $2.74 | $1.91 |
| Distance from 52-week high | -50.17% | -8.12% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | -8.64% | +3.33% |
| Average volume | 2.01M | 230.41K |
| Shares outstanding | 95.65M | 53.69M |
| Employees | 2,700 | 158 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TKNO has outperformed MYGN by 109.4 percentage points over the past year.
About Myriad Genetics
MYGN stock →Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics.
Healthcare · Diagnostics & Research · 2,700 employees
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 158 employees
MYGN vs TKNO FAQ
Which is bigger, Myriad Genetics or Alpha Teknova?
Alpha Teknova (TKNO) is larger, with a market capitalization of $467.62M compared with $409.38M for Myriad Genetics (MYGN).
Which stock has performed better over the past year, MYGN or TKNO?
TKNO returned +66.22% over the past 12 months, compared with -43.16% for MYGN (price return, excluding dividends). Past performance does not predict future results.
Are Myriad Genetics and Alpha Teknova in the same industry?
Both are in the Healthcare sector, but in different industries: Diagnostics & Research for Myriad Genetics and Drug Manufacturers - Specialty & Generic for Alpha Teknova.